secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emmaus Life Sciences, Inc. (EMMA)
CIK:        0000822370
Form:       8-K
Filed at:   2024-10-25T23:59:59+00:00
Accession:  0001213900-24-090765
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emmaus Life Sciences engages Marcum LLP as new auditor for FY 2024
------------------------------------------------------------------

- Audit Committee appointed Marcum LLP as independent accountant on October 22, 2024.
- Marcum will audit the quarter ended September 30, 2024 and year ending December 31, 2024.
- Company did not consult Marcum on any matters described in Item 304(a)(2) of Reg S-K prior to engagement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/822370/000121390024090765/0001213900-24-090765-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/822370/000121390024090765/ea0218652-8k_emmaus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-090765

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer